22 July 2026

Guidelines Obesity Pharmaceuticals

ACP backs GLP-1s first for obesity

22 July 2026

Clinical research Obesity psoriatic arthritis

Higher BMI may blunt TNF inhibitor response in PsA

8 July 2026

Clinical research Gastro Obesity

Gut resurfacing may curb post-GLP-1 weight regain

8 July 2026

Clinical research Diabetes Obesity Pharmaceuticals

Triple hormone receptor agonist improves glycaemic control and bodyweight reduction in T2D

10 June 2026

Diabetes Obesity Pharmaceuticals

How do people feel about using GLP-1 RAs?

18 March 2026

Government PBAC Pharmaceuticals

PBAC maps path to PBS access for GLP-1 RA obesity therapies

26 November 2025

Obesity Pharmaceuticals

GLP-1s could help avoid follow-up bariatric surgery

15 October 2025

Obesity Pharmaceuticals

GLP-1 RAs linked to rising rates of hair loss

1 October 2025

Obesity Research

BMJ retracts vinegar weight loss trial

11 December 2024

Obesity Pharmaceuticals

Even more things GLP-1 RAs can do

18 September 2024

Alopecia Areata Obesity Paediatrics Psoriasis

Obese kids risk eczema, psoriasis, alopecia

24 July 2024

Obesity

Tirzepatide beats semaglutide for weight loss

15 May 2024

Nutrition Obesity Paediatrics

Iron deficiency risk increases in overweight and obese children

25 January 2023

Nutrition Obesity

Obesity blunts benefits of vitamin D supplements